Neogen Q4 FY26 net loss narrows to $11.3 million; revenue slips 0.1% to $225.3 million

• Neogen posted Q4 FY26 revenue of $225.3 million, down 0.1% year over year.
• Net loss narrowed to $11.3 million, or $(0.05) per diluted share, from a much larger loss a year earlier.
• Adjusted EBITDA (non-GAAP) rose to $45.4 million from $40.6 million; margin widened to 20.2% from 18%.
• Food Safety revenue increased 3.1% to $166.8 million, while Animal Safety revenue fell 8.2% to $58.5 million.
• Guided FY27 revenue at $880-$885 million, with adjusted EBITDA (non-GAAP) of $180-$182 million; Petrifilm transition slated to start November 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neogen Corporation published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.